Diets
ketogenic diet decreases major depression and anxiety symptoms
In plain terms: Does a ketogenic diet reduce depression or anxiety?
Part of: 🥗 ketogenic diet
The best-controlled trial and a 2026 meta-analysis find the therapeutic value uncertain and no clear advantage over comparator diets, so the claim is not yet supported.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
The evidence (18)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Laurent N. 2026 · study_type: observational | n-of-1 | supports | low | Single retrospective case report (n=1) of 25-week KMT in treatment-resistant PTSD; PCL-5 32->2, PHQ-9 10->0, GAD-7 6->0, with DASS-42 confirming resolution of depressive/anxious/stress symptoms. |
| Bellamy EL. 2026 · study_type: observational | observational | supports | low | Retrospective, uncontrolled evaluation of online group KMT (n=19) with baseline PHQ-9/GAD-7 >4; PHQ-9 fell 13->5 (62% reduction) and GAD-7 fell 13->7 (46% reduction) over 12 weeks, most reaching clinically meaningful improvement. |
| Gao 2026 · JAMA Psychiatry | RCT | mixed | moderate | First well-controlled RCT in treatment-resistant depression — designed because RCT evidence was lacking; no clear efficacy signal, adherence poor. |
| Carneiro RAVD et al 2026 · study_type: observational | observational | mixed | low | Single-center prospective cohort (n=17) of modified Atkins diet in adult drug-resistant epilepsy over up to 12 months; anxiety (HADS-A) improved significantly (-4.38, p=.01) independent of seizure changes, though depression (HADS-D) not rep |
| Filippi F et al 2026 · study_type: observational | observational | mixed | low | Single-arm open-label study (n=16 MS patients) on 3-month KD; DASS-21 depression subscale improved (3.18 vs 6.15, p=0.036) and anxiety subscale improved (5.15 vs 1.55, p=0.019) from baseline to 3 months. |
| Janssen-Aguilar 2025 · Epilepsia Open | RCT | mixed | low | Small feasibility RCT found modified Atkins (ketogenic) diet reduced depression and anxiety at 6 weeks without significant between-group difference vs control diet. |
| Laurent N et al 2025 · study_type: observational | n-of-1 | supports | low | Single retrospective case study (n=1) of KMT (1.5:1 ratio) with multidisciplinary support in a 47-year-old woman with lifelong treatment-resistant MDD; PHQ-9 25->0 and GAD-7 3->0 by 2-4 months, full remission achieved. |
| Decker DD et al 2025 · study_type: observational | observational | supports | low | 10-12 week single-arm pilot (n=16 completers) of well-formulated KD as adjunct in college students with MDD; PHQ-9 fell 69% and HRSD fell 71% (both p<0.001), with improvement starting 2-6 weeks in. |
| Frank GKW et al 2026 · study_type: observational | observational | mixed | low | Uncontrolled single-arm feasibility trial (n=22, 18 completed) of 14-week weight-maintaining KD in adults with anorexia nervosa. Depression scores decreased over time alongside EDE-Q subscales (MANCOVA p<0.001); 72% within normal range for |
| Rigby 2025 · BMC Psychiatry | observational | mixed | low | Process evaluation of a bipolar ketogenic-diet pilot found feasibility and some symptom benefit but high burden/attrition. |
| Liang Y et al 2026 · study_type: observational | observational | mixed | low | 12-week single-arm pilot (n=20 completers, BED patients) of dietitian-supported KD; PHQ-9 depression scores fell from 16.5 to 8.2 (p=0.005) alongside binge-eating improvement. |
| Janssen-Aguilar 2026 · JAMA Psychiatry | meta-analysis | tested-null | high | Systematic review/meta-analysis: therapeutic value of KD in psychiatric populations remains uncertain; evidence weak/heterogeneous. |
| Bellamy 2024 · Front Nutr | observational | supports | low | Qualitative thematic analysis reported participants experienced improved well-being and reduced depressive symptoms on a ketogenic diet. |
| Mela 2026 · Brain Behav Immun | RCT | contradicts | moderate | Pilot RCT: keto LESS effective than Mediterranean diet at reducing depression/anxiety in obesity. |
| Campbell 2025 · BJPsych Open | observational | mixed | low | Uncontrolled pilot of ketogenic diet in bipolar disorder reported improvements in mood/psychiatric and metabolic measures. |
| Varaee 2023 · J Affective Disorders | meta-analysis | tested-null | moderate | Meta-analysis of low-carb diets: no significant overall effect on depression/anxiety. |
| Brietzke 2026 · J Affective Disorders | observational | mixed | low | Uncontrolled pilot of supervised KD in moderate-severe depression: feasible, preliminary signal only. |
| Gao 2024 · J Psychiatr Res | mechanism | mixed | moderate | Protocol/rationale paper for a treatment-resistant-depression ketogenic RCT summarizing preclinical/mechanistic basis; not itself outcome evidence. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.